Paju-si, South Korea

Namheon Kim

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Namheon Kim: Innovator in Machine Learning and Cognitive Impairment Classification

Introduction

Namheon Kim is a notable inventor based in Paju-si, South Korea. He has made significant contributions to the fields of machine learning and cognitive impairment classification. With a total of 2 patents, his work showcases innovative approaches to complex problems.

Latest Patents

Namheon Kim's latest patents include a "Machine learning method and apparatus using steps feature selection based on genetic algorithm." This invention focuses on defining a feature set, generating feature combinations, and constructing feature models to enhance prediction accuracy. Another significant patent is the "Method, server, and computer program for classifying severe cognitive impairment patients by analyzing EEG data." This method involves collecting EEG data, classifying users based on cognitive impairment levels, and providing a structured approach to understanding cognitive health.

Career Highlights

Throughout his career, Namheon Kim has worked with various organizations, including Imedisync, Inc. and the Catholic University of Korea Industry-Academic Cooperation Foundation. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Namheon Kim has collaborated with notable colleagues such as Seung Wan Kang and Dong Won Yang. Their combined expertise has contributed to the advancement of technologies in their respective fields.

Conclusion

Namheon Kim's innovative work in machine learning and cognitive impairment classification highlights his role as a leading inventor. His contributions continue to impact the fields of technology and healthcare significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…